1618648-11-5

Basic information

• Product Name: (4-{[(1H-pyrazole-4-carbonyl)amino]methyl}benzyl)carbamic acid tert-butyl ester
• Synonyms: (4-{[(1H-pyrazole-4-carbonyl)amino]methyl}benzyl)carbamic acid tert-butyl ester
• CAS NO: 1618648-11-5
• Molecular Weight: 330.387
• Mol File: 1618648-11-5.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: (4-{[(1H-pyrazole-4-carbonyl)amino]methyl}benzyl)carbamic acid tert-butyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: (4-{[(1H-pyrazole-4-carbonyl)amino]methyl}benzyl)carbamic acid tert-butyl ester(1618648-11-5)
• EPA Substance Registry System: (4-{[(1H-pyrazole-4-carbonyl)amino]methyl}benzyl)carbamic acid tert-butyl ester(1618648-11-5)

Safety Data

• Hazardous Substances Data: 1618648-11-5(Hazardous Substances Data)

Upstream product

• 37718-11-9 1H-pyrazole-4-carboxylic acid 
• 108468-00-4 tert-butyl 4-(aminomethyl)benzylcarbamate 

Downstream Products

• 1618699-45-8 1-(2-methylquinolin-6-ylmethyl)-1H-pyrazole-4-carboxylic acid 4-aminomethylbenzylamide 
• 1618648-12-6 [4-({[1-(2-methylquinolin-6-ylmethyl)-1H-pyrazole-4-carbonyl]amino}methyl)benzyl]carbamic acid tert-butyl ester 

Relevant articles and documents

BENZYLAMINE DERIVATIVES

The present invention provides compounds of formula (I): compositions comprising such compounds; the use of such compounds in therapy (for example in the treatment or prevention of a disease or condition in which plasma kallikrein activity is implicated); and methods of treating patients with such compounds; wherein R1 to R3, R5 to R9, A, P, V, W, X, Y and Z are as defined herein.